CELEX: 62011TA0502
Language: en
Date: 2013-05-17 00:00:00
Title: Case T-502/11: Judgment of the General Court of 17 May 2013 — Sanofi Pasteur MSD v OHIM — Mundipharma (Representation of two devices of crossing sickles) (Community trade mark — Opposition proceedings — Application for Community figurative mark representing two devices of crossing sickles — Earlier national and international figurative marks representing two devices of ribbons — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation No 207/2009)

29.6.2013   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 189/21
            
         Judgment of the General Court of 17 May 2013 — Sanofi Pasteur MSD v OHIM — Mundipharma (Representation of two devices of crossing sickles)
   (Case T-502/11) (1)
   
   (Community trade mark - Opposition proceedings - Application for Community figurative mark representing two devices of crossing sickles - Earlier national and international figurative marks representing two devices of ribbons - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation No 207/2009)
   2013/C 189/41
   Language of the case: German
   
      Parties
   
   
      Applicant: Sanofi Pasteur MSD SNC (Lyon, France) (represented by: T. de Haan, P. Péters and V. Wellens, lawyers)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: G. Schneider, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM: Mundipharma AG (Basel, Switzerland) (represented by: F. Nielsen, lawyer)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of OHIM of 22 July 2011 (Case R 1904/2010-4), relating to opposition proceedings between Sanofi Pasteur MSD SNC and Mundipharma AG
   
      Operative part of the judgment
   
   The Court:
   
               1.
            
            
               Dismisses the action;
            
         
               2.
            
            
               Orders Sanofi Pasteur MSD SNC to pay the costs.
            
         
      (1)  OJ C 340, 19.11.2011.